Lyrical Asset Management LP Has $231.62 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Lyrical Asset Management LP raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 771,691 shares of the company’s stock after purchasing an additional 177 shares during the quarter. HCA Healthcare accounts for 3.5% of Lyrical Asset Management LP’s investment portfolio, making the stock its 13th biggest holding. Lyrical Asset Management LP owned about 0.30% of HCA Healthcare worth $231,623,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in HCA. MML Investors Services LLC grew its holdings in shares of HCA Healthcare by 31.7% during the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock valued at $7,241,000 after acquiring an additional 4,285 shares in the last quarter. Meritage Group LP acquired a new position in shares of HCA Healthcare during the 3rd quarter valued at about $150,548,000. Galvin Gaustad & Stein LLC bought a new position in HCA Healthcare during the fourth quarter valued at about $18,044,000. NRI Wealth Management LC bought a new stake in shares of HCA Healthcare in the 4th quarter worth approximately $2,896,000. Finally, Czech National Bank raised its stake in shares of HCA Healthcare by 4.5% in the fourth quarter. Czech National Bank now owns 39,543 shares of the company’s stock valued at $11,869,000 after purchasing an additional 1,691 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Down 4.8 %

HCA opened at $332.53 on Friday. The firm has a 50 day simple moving average of $327.23 and a 200 day simple moving average of $339.47. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a market cap of $81.87 billion, a price-to-earnings ratio of 15.14, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the firm earned $5.90 earnings per share. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were issued a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date was Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. HCA Healthcare’s payout ratio is 13.11%.

Insider Buying and Selling

In other news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.30% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. Barclays cut their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research note on Monday, January 27th. KeyCorp dropped their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Bank of America lowered their price target on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 27th. Finally, JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.